Clinical Research Directory
Browse clinical research sites, groups, and studies.
Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
Sponsor: Centre Antoine Lacassagne
Summary
Thanks to the intrinsic qualities of the proton beam, proton therapy will reduce adverse effects of irradiation. The Proteus®One is the latest generation of proton therapy equipment, enabling the Centre Antoine Lacassagne to expand its range of treatments by carrying out new proton therapy treatments. It has an innovative compact isocentric rotating head (Gantry) that allows the radiation beam to be directed at different angles around the patient. In some cases, two beams are used to treat tumours, and by convention, both beams are delivered during the same session. However, it is necessary to position the patient before each beam, which is time-consuming because 2 beams have to be positioned very precisely each day. The aim of this study is therefore to assess the toxicity of proton therapy delivered by a single daily beam compared with proton therapy delivered by two daily beams, which is the conventional technique.
Official title: Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy : Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
106
Start Date
2023-09-13
Completion Date
2031-10-01
Last Updated
2024-09-25
Healthy Volunteers
No
Interventions
Proteus ONE one daily beam
A single daily beam is used, doubling the dose delivered for this treatment incidence.
Proteus ONE two daily beam
two daily beams are used, in accordance with the initial treatment plan and the patient's standard of care
Locations (1)
Centre Antoine lacassagne
Nice, France